Ludovic Helfgott/LinkedIn
Mar 11, 2026, 14:54
Ludovic Helfgott: Grateful for Generosity in Supporting Patients with Hemophilia and Hemoglobinopathies
Ludovic Helfgott, Executive Vice President, Product and Portfolio Strategy at Novo Nordisk, shared a post on LinkedIn:
“One of the most gratifying things in the life of a Chairman of a not-for-profit organization is to take money directly from the pockets of your great colleagues and friends …for a good cause …and still see them smile afterwards.
Thanks to Maziar Mike Doustdar, Martin Holst Lange, Kasper Bødker Mejlvang, Habib Bennaceur (and many others) for your wonderful generosity in helping patients with hemophilia, hemoglobinopathies or diabetes around the world.”
Stay updated with Hemostasis Today.
-
Mar 11, 2026, 14:26Cathy Harrison: Hemophilia Nurses Advocating for People Living With Bleeding Disorders
-
Mar 11, 2026, 13:47Carlos Andrés Vergara Sánchez: AI-Driven CCTA Plaque Quantification for Better ASCVD Risk Assessment
-
Mar 11, 2026, 13:44Scott Cameron: Metformin, Aspirin, and Sex-Specific Effects in Abdominal Aortic Aneurysm Growth
-
Mar 11, 2026, 13:35Erwin Loh: Can Fiber-Rich Foods Help Reduce Heart Disease Risk in Night Shift Workers?
-
Mar 11, 2026, 13:33Tareq Abadl: Differentiating Cold Agglutination from Hemolysis
-
Mar 11, 2026, 13:13Louise St Germain Bannon: Celebrating Cary Clark’s 25 Years of Dedication to the ISTH Community
-
Mar 11, 2026, 13:04Philip Wenzel: The Role of MyD88 in the Inflammatory Transition from Hypertension to Heart Failure
-
Mar 11, 2026, 12:58Santagata Davide: How Biological Sex Influences Thrombotic Risk in Patients with Cancer?
-
Mar 10, 2026, 14:33Eugene Tang: A Look at What’s Happening in Life After Stroke Research Across Europe at ELASF 2026